Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
An anti-idiotypic vascular endothelial growth factor antibody, an Fab fragment,
and pharmaceutical compositions thereof, being ligands of the human KDR receptor
or of the murine flk-1 receptor and not a ligand of flt are provided.